ST吉药(300108) - 2014 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2014 was CNY 40,934,455.24, representing a 36.6% increase compared to CNY 29,966,164.09 in the same period last year[9] - Net profit attributable to ordinary shareholders was CNY 6,025,053.87, up 7.26% from CNY 5,617,032.72 year-on-year[9] - Basic earnings per share increased by 12.5% to CNY 0.045 from CNY 0.04 in the same period last year[9] - Operating profit increased by 69.99% to 7,738,874.88 yuan, attributed to higher product sales and increased average selling prices[17] - The total profit for Q1 2014 was CNY 7,165,659.19, which is an increase of 6.8% from CNY 6,708,914.81 in Q1 2013[42] - The company's net profit margin improved, with net profit increasing to CNY 7,738,874.88 from CNY 4,552,473.56, representing a growth of about 69.0%[40] Cash Flow - The net cash flow from operating activities was negative CNY 25,603,240.08, a decline of 18.01% compared to negative CNY 21,696,627.54 in the previous year[9] - Cash inflow from operating activities was 40,606,930.20 yuan, a growth of 38.48% year-on-year, reflecting increased sales revenue[18] - Cash outflow from operating activities rose to 54,989,652.28 yuan, up 33.07% year-on-year, primarily due to increased material purchases[18] - The cash flow from operating activities showed a net outflow of CNY -25,603,240.08, compared to CNY -21,696,627.54 in the same period last year[47] - The net cash flow from operating activities was -26,996,906.67 CNY, compared to -23,608,906.22 CNY in the previous year, indicating a decline of approximately 10.1%[51] - The net increase in cash and cash equivalents was -28,141,536.83 CNY, compared to -4,314,882.22 CNY in the same period last year, reflecting a significant decline[52] Assets and Liabilities - Total assets at the end of the reporting period were CNY 473,054,405.37, a 1.55% increase from CNY 465,831,664.21 at the end of the previous year[9] - Current assets rose to CNY 180,599,734.69, up from CNY 167,514,289.03, indicating an increase of about 7.5%[34] - Total liabilities increased to CNY 69,029,061.13 from CNY 67,833,656.14, reflecting a growth of approximately 1.8%[36] - Shareholders' equity rose to CNY 404,025,344.24 from CNY 397,998,008.07, indicating an increase of about 1.5%[36] Sales and Expenses - The company's revenue for the reporting period was 40,934,455.24 yuan, an increase of 36.60% year-on-year, driven by a 28.12% increase in product sales volume and higher sales of premium products[17] - Sales expenses rose to 3,640,858.88 yuan, up 47.02% year-on-year, due to increased sales volume and growth in the southern market[17] - Operating costs rose to CNY 33,195,580.36 from CNY 25,413,690.53, which is an increase of approximately 30.6%[40] - Sales expenses increased to CNY 3,334,526.11 in Q1 2014, up from CNY 2,449,511.25 in the previous year, reflecting a rise of 36.1%[44] - Management expenses also rose to CNY 3,902,969.91, compared to CNY 2,979,554.66 in Q1 2013, marking a 30.9% increase[44] Future Outlook - The company expects continued improvement in performance due to recovering demand in the silica gel market, despite challenges from increased depreciation and labor costs[11] - The company expects continued improvement in sales performance in the next quarter due to recovering demand in the silicone rubber market[19] - The company plans to enhance product industrialization and expand sales channels to ensure stable growth in performance[11] - The company plans to enhance cost efficiency through technological and management innovations, aiming for stable growth in performance[19] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,605[12] - The cash dividend policy was approved, with a proposal to distribute 1 RMB per 10 shares based on a total share capital of 13,520 million shares[29] - No cash dividends will be distributed in the first quarter of 2014[30] - There are no plans for share buybacks or significant shareholder actions reported during the period[31] Government Subsidies and Fundraising - The company received government subsidies totaling CNY 429,530.55 during the reporting period[10] - The total amount of raised funds for the quarter is 26,624,000 RMB[26] - The cumulative amount of raised funds used is 23,574.29 million RMB, with a 0% change in purpose[26] - The company has raised 113 million RMB in excess funds, with specific allocations for investments and loan repayments[27]